76285-67-1 Usage
Structure
A benzene ring with an amine group and an alkylamine group attached (the compound consists of a benzene ring with an amino group attached to the methyl group, which is connected to a phenyl group and an ethyl group)
Usage
Used in the synthesis of pharmaceutical drugs (the compound is used to create various pharmaceutical drugs through chemical reactions)
Potential applications
Organic chemistry and drug development (the compound may have potential applications in the field of organic chemistry and the development of new drugs)
Therapeutic properties
Potential binding affinity with certain receptors in the central nervous system (the compound has been studied for its potential therapeutic properties and may bind to certain receptors in the central nervous system)
Safety precautions
Handle with proper safety precautions to avoid toxic or irritating effects (the compound may have toxic or irritating effects if not handled properly and should be handled with care)
Check Digit Verification of cas no
The CAS Registry Mumber 76285-67-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,2,8 and 5 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 76285-67:
(7*7)+(6*6)+(5*2)+(4*8)+(3*5)+(2*6)+(1*7)=161
161 % 10 = 1
So 76285-67-1 is a valid CAS Registry Number.
76285-67-1Relevant academic research and scientific papers
Synthesis and Anticonvulsant Activity of Analogues of 4-Amino-N-(1-phenylethyl)benzamide
Clark, C. Randall,Davenport, Timothy W.
, p. 1214 - 1218 (2007/10/02)
A group of amides and amines related to 4-amino-N-(1-phenylethyl)benzamide, 1, were prepared in a study on the relationship of structure to anticonvulsant activity in this compound. Acylation and alkylation of the amino group of 1 resulted in almost total loss of anticonvulsant activity. Insertion of a methylene between the 4-amino group and the aromatic ring of 1 produced a slight increase in anticonvulsant potency and a significant increase in toxicity. Hydride reduction of the amide carbonyl in 1 also yielded compounds having a slightly lower ED50 against convulsions induced by electroshock and a much lower TD50 in the rotorod assay. Modification of the 1-phenylethyl group of 1 also decreased anticonvulsant potency.
